David Smith

Currently, David V.
Smith serves as Independent Director at Codexis, Inc. since 2016, Director at Neurelis, Inc. since 2021, Director at Acepodia Biotechnologies, Ltd. since 2022, and Strategic Advisor at Monterey Innovation Acquisition Corp.
Formerly, the roles include Director at Perlegen Sciences, Inc. from 2006 to 2009, Independent Director at OncoGenex Pharmaceuticals, Inc., Director at Acepodia, Inc. (United States) from 2022 to 2023, Independent Director at IO Biotech, Inc. from 2022 to 2026, CFO, Principal Accounting Officer, VP & Controller at Chiron Corp.
from 1999 to 2006, Principal at Genentech, Inc. from 1988 to 1997, Principal at International Business Machines Corp., Principal at Syntex Corp., Chief Financial Officer & Vice President-Finance at Anergen, Inc. from 1997 to 1999, Chief Financial Officer & Executive Vice President at Thoratec Corp.
from 2006 to 2011, Chief Financial Officer & Executive Vice President at Five Prime Therapeutics, Inc. from 2018 to 2021, and Chief Operating Officer at IntegenX, Inc. from 2012 to 2018.
Education includes an MBA from Golden Gate University conferred in 1987 and an undergraduate degree from Willamette University conferred in 1981.